1. Home
  2. TLF vs CVKD Comparison

TLF vs CVKD Comparison

Compare TLF & CVKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tandy Leather Factory Inc.

TLF

Tandy Leather Factory Inc.

HOLD

Current Price

$2.68

Market Cap

21.2M

ML Signal

HOLD

Logo Cadrenal Therapeutics Inc.

CVKD

Cadrenal Therapeutics Inc.

HOLD

Current Price

$7.43

Market Cap

20.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TLF
CVKD
Founded
1980
2022
Country
United States
United States
Employees
N/A
N/A
Industry
Apparel
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
21.2M
20.7M
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
TLF
CVKD
Price
$2.68
$7.43
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$32.00
AVG Volume (30 Days)
14.0K
78.1K
Earning Date
11-10-2025
11-10-2025
Dividend Yield
56.60%
N/A
EPS Growth
308.92
N/A
EPS
1.18
N/A
Revenue
$74,550,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$2.26
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.56
$6.76
52 Week High
$5.48
$22.90

Technical Indicators

Market Signals
Indicator
TLF
CVKD
Relative Strength Index (RSI) 45.73 36.34
Support Level $2.60 $6.76
Resistance Level $2.74 $12.50
Average True Range (ATR) 0.08 1.09
MACD 0.01 -0.24
Stochastic Oscillator 39.68 13.50

Price Performance

Historical Comparison
TLF
CVKD

About TLF Tandy Leather Factory Inc.

Tandy Leather Factory Inc is a specialty retailers of leather and leathercraft-related items. Its primary line of business is the sale of leather, leather crafts, and related supplies. Its broad line of leather and related products includes leather, leatherworking tools, leather dyes and finishes, and do-it-yourself kits. Its products include Leather, tools, Hardware, Supplies, Kits, Books and Patterns, and Gift cards. The company sells its products primarily through company-owned stores and through orders generated from its global websites, and through direct account representatives in its commercial division. Geographically the company operates within the United States, Canada and others and generates the highest revenue from the United States.

About CVKD Cadrenal Therapeutics Inc.

Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.

Share on Social Networks: